Who Paid My Doc
A Phase 3B, Randomized, Open-Label Study Ofhtx-011 As the Foundation of A Non-Opioid, Multimodal Analgesic Regimen to Decrease Opioid Use Following Unilateral Open Inguinal Herniorrhaphy
ClinicalTrials.gov NCT03907176
Research payments
$1,200
Through program year 2023, $1,200 in research payments was reported against A Phase 3B, Randomized, Open-Label Study Ofhtx-011 As the Foundation of A Non-Opioid, Multimodal Analgesic Regimen to Decrease Opioid Use Following Unilateral Open Inguinal Herniorrhaphy, across 1 payment, paid by Heron Therapeutics, Inc..
- Paid by
- Heron Therapeutics, Inc.
- ClinicalTrials.gov
- NCT03907176
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | Research | $1,200 | 1 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
1 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.